AIM2 also has protumor effects in oral squamous cell carcinoma [220], the start and spread of benign prostate hyperplasia [221], and chemically-induced hepatic cell carcinoma (HCC) [222]. This evidence concerns the gene AIM2 and hepatocellular carcinoma.